Literature DB >> 16043414

Detection of IL-20 and its receptors on psoriatic skin.

Chi-Chen Wei1, Wei-Yu Chen, Yo-Ching Wang, Po-Jen Chen, Julia Yu-Yun Lee, Tak-Wah Wong, Wen Chieh Chen, Jen-Chin Wu, Guan-Ying Chen, Ming-Shi Chang, Yu-Chih Lin.   

Abstract

The aim of this study was to investigate the expression of interleukin-20 (IL-20) and its receptors on psoriatic skin by immunohistochemical analysis and to evaluate the correlation of CD8-positive T lymphocytes with epidermal proliferation. Overexpression of IL-20 and its receptors was detected in the keratinocytes of the lesional skin of psoriasis and spongiotic dermatitis. The expression pattern of IL-20 spreads throughout the whole layer of epidermis, while IL-19 was expressed in up to three or four layers suprabasally. The serum level of IL-20 in psoriatic patients was significantly lower than that in healthy controls. IL-20 upregulated KGF transcripts on CD8-positive T cells. We hypothesize that overexpression of IL-20 is correlated with keratinocyte proliferation that acts through their receptor complex expressed by keratinocytes themselves. Furthermore, IL-20 can stimulate CD8-positive lymphocytes to produce KGF, which may contribute to sustaining the hyperproliferative status of the keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043414     DOI: 10.1016/j.clim.2005.06.012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  24 in total

Review 1.  Immunopathogenesis of psoriasis.

Authors:  Brian J Nickoloff; Jian-Zhong Qin; Frank O Nestle
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

Review 2.  Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.

Authors:  Ya-Chu Tsai; Tsen-Fang Tsai
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-06       Impact factor: 5.346

3.  IL-24 is expressed during wound repair and inhibits TGFalpha-induced migration and proliferation of keratinocytes.

Authors:  Nancy J Poindexter; Ryan R Williams; Garth Powis; Emily Jen; Abigail S Caudle; Sunil Chada; Elizabeth A Grimm
Journal:  Exp Dermatol       Date:  2010-08       Impact factor: 3.960

Review 4.  What is a role of haeme oxygenase-1 in psoriasis? Current concepts of pathogenesis.

Authors:  Anna Wojas-Pelc; Janusz Marcinkiewicz
Journal:  Int J Exp Pathol       Date:  2007-04       Impact factor: 1.925

5.  IL-20 is involved in obesity by modulation of adipogenesis and macrophage dysregulation.

Authors:  Yu-Hsiang Hsu; Chih-Hsing Wu; Chiao-Juno Chiu; Wei-Ting Chen; Yi-Chieh Chang; Martin Wabitsch; Ming-Shi Chang
Journal:  Immunology       Date:  2021-08-30       Impact factor: 7.397

6.  Anti-IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss.

Authors:  Yu-Hsiang Hsu; Wei-Yu Chen; Chien-Hui Chan; Chih-Hsing Wu; Zih-Jie Sun; Ming-Shi Chang
Journal:  J Exp Med       Date:  2011-08-15       Impact factor: 14.307

7.  Association of the IL-10 gene family locus on chromosome 1 with juvenile idiopathic arthritis (JIA).

Authors:  Ebun Omoyinmi; Paola Forabosco; Raja Hamaoui; Annette Bryant; Anne Hinks; Simona Ursu; Lucy R Wedderburn; Wendy Thomson; Cathryn M Lewis; Patricia Woo
Journal:  PLoS One       Date:  2012-10-18       Impact factor: 3.240

8.  Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment.

Authors:  Maria C Lebre; Christina L Jonckheere; Maarten C Kraan; Arno W R van Kuijk; Jan D Bos; Menno de Rie; Danielle M Gerlag; Paul P Tak
Journal:  Arthritis Res Ther       Date:  2012-09-24       Impact factor: 5.156

9.  First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti-IL-20 Monoclonal Antibody in Patients with Psoriasis.

Authors:  Alice B Gottlieb; James G Krueger; Mia Sandberg Lundblad; Marie Göthberg; Brett E Skolnick
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

10.  Anti-IL-20 Monoclonal Antibody Suppresses Prostate Cancer Growth and Bone Osteolysis in Murine Models.

Authors:  Yu-Hsiang Hsu; Cheng-Ying Wu; Chung-Hsi Hsing; Wei-Ting Lai; Li-Wha Wu; Ming-Shi Chang
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.